Introduction
The detection of DNA adducts has become a popular approach for studying chemical mutagenesis and carcinogenesis, and many DNA adducts have been detected in human DNA. 1 Because DNA adducts are present at quite low levels in DNA in vivo, highly sensitive 32 P-postlabeling techniques have been used for their detection and quantification. 2, 3 However, the 32 P-postlabeling method is not able to provide structural information, and many investigators cannot use this method because it requires the troublesome handling of radioactive materials.
On the other hand, mass spectrometry (MS) is a powerful tool for structural identification and sensitive analysis. When liquid chromatography (LC) is used in conjunction with MS, many kinds of DNA adducts can be detected, along with structural information from MS measurements. Furthermore, as great advances in MS instrumentation have been achieved in recent years to enhance the sensitivity, very low concentrations of DNA adducts can be detected and quantitated. 4, 5 Therefore, it may be useful to establish convenient methods based on LC/MS as key tools in the DNA-adducts-based approach to study mutagenesis and carcinogenesis.
In DNA adduct analysis by LC/MS, there is an inevitable and serious problem in that a very low concentration of DNA adducts is present with a large excess of normal deoxynucleosides. In fact, DNA adducts are found with very low probability in normal deoxynucleosides in DNA in vivo, typically corresponding to a few adducts per approximately 10 8 -10 9 normal deoxynucleosides. Because the injection quantity of samples is limited by the concentration of the normal nucleosides, it is highly desirable for DNA adduct analysis to reduce the coexisting normal deoxynucleosides selectively and, if possible, to simultaneously enrich the DNA adducts of interest. From this point of view, we planned to produce a simple device for pretreating DNA samples in DNA adduct analysis by LC/MS.
Recently, an efficient pretreatment method was developed for proteome analysis in which target peptides exist in a large excess of contaminating compounds, similar to that encountered in DNA adduct analysis.
Ishihama et al. reported the development of stop and go extraction tip (StageTip), which can remove contaminating peptides and concentrate trace target peptides in simple steps. 6 StageTip combines the flexibility and low price of self-made tools with the ease of use, recovery, reproducibility, and robustness typical for mass-manufactured devices.
In this paper, we report a simple pretreatment method for DNA adduct analysis through the use of StageTip to remove normal deoxynucleosides or bases, and to enrich the DNA adducts selectively ( Fig. 1(a) ). Moreover, we accomplished a one-shot injection of the total amount of the target adducts on StageTip to significantly improve the sensitivity in concentration without losing the valuable sample. We have developed a simple method to significantly improve the sensitivity in the LC/MS analysis of DNA adducts. A preconcentration tip for the selective recovery of DNA adducts was prepared. Using this tip, the total amount of DNA adducts in a treated DNA sample was injected in a one-shot manner into an LC/MS system. We were able to improve the sensitivity by more than one order of magnitude in concentration. This method will be a useful tool for the quantitative determination of trace DNA adducts. 
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Experimental
Reagents and chemicals 2′-Deoxyguanosine hydrate (dG), 2′-deoxycytidine (dC), 2′-deoxyadenosine monohydrate (dA), thymidine (T), and guanine (Gua) were purchased from Tokyo Chemical Industry Co., Ltd. Adenine (Ade) was obtained from Nacalai Tesque. Cyclic 1, N 2 -propano-2′-deoxyguanosine (CPrdG) was synthesized as previously reported. 
Apparatus
The loading of several solutions to StageTip was performed using a syringe pump, KDS-100 (Kd Scientific, USA). High performance liquid chromatography (HPLC) separations were performed on an HP1100 series (Hewlett-Packard, USA) or Shimadzu Prominence HPLC system (Shimadzu, Japan). LC-electrospray ionization (ESI)/MS/MS analysis was performed on a Shimadzu Prominence HPLC system equipped with a 3200 QTRAP LC/MS/MS (AB SCIEX, Canada) system with a TurboV source and an electrospray ionization probe.
Materials
Empore disks (ODS) were obtained from 3M. The packing material of Sep-Pak cartridges (packing material: ODS, Waters) was used as the packing material on the Empore disk. Micropipette tips of 200 μL capacity were purchased from QSP (cat. #110). The blunt-ended of a syringe needle (Shimadzu, Parts No., 228-18216-91) was used for cutting the Empore disks. The plunger of a microsyringe fitting into the blunt-ended of syringe needle was used for packing pieces of the Empore disk in pipette tips. 6 A stainless-steel needle moiety, which was removed from a microsyringe for HPLC, was used as a hollow stainless-steel needle for total volume injection ( Fig. 1(b) ).
Producing the StageTip
The procedure for producing the StageTip was based on that previously reported. 6 In brief, a small disk was stamped out from the Empore disk using the blunt-end of a syringe needle. After placing the cutter inside the 200-μL micropipette tips, the disk was released and pressed using the plunger. After pressing the small disk, the packing material and methanol were added, and pressure was applied by a 2.5-mL syringe. Finally, the StageTip was capped with absorbent cotton (Fig. 1(a) ).
StageTip treatment
Each solution was loaded from the back of the StageTip at flow rates of 1.2 mL h -1 (all conditioning treatments, all sample injection treatments, extraction from the tips about each study of the retention capacity of ODS), 3.0 mL h -1 (washing), and 0.6 mL h -1 (sample injection in total volume injection study). We initially ran 100 μL of methanol followed by 200 μL of water through the StageTip for conditioning, and thus 1 mL of the sample solution was loaded in each experiment. After sample loading, 3 mL or 600 μL of water was loaded to eliminate the normal nucleosides or bases, respectively, which can remove almost all of the normal nucleosides and bases. Forty microliters of methanol were used for extraction except for total volume injection. After extraction, 40 μL of water was added to the extract for HPLC analysis. In the total volume injection analysis of nucleosides or bases, 60 μL of a 40% methanol-water solution or 40 μL of a 50% methanol-water solution was used for extraction, respectively.
Calculating recovery ratios
The recovery ratios of each DNA adduct were calculated using the ratios of the peak areas of enriched samples to those of the target samples of the expected equivalent number of moles after enrichment. The recovery ratios of normal deoxynucleosides and bases were calculated using the ratios of the peak areas after enrichment to those before enrichment.
Results and Discussion
Evaluation of the retention capacity of StageTip for nucleoside
CPrdG (Fig. 2) , which is derived from acetaldehyde or crotonaldehyde, being a mutagen and carcinogen, and detected in DNA from human lung and liver, was used as the model target of DNA adducts in this study. 4, 7, 9 The quantification of CPrdG would be important in assessing their potential roles as human carcinogens. We prepared a standard sample including a set of four normal deoxynucleosides and CPrdG (the concentration of each sample was 10 -4 M) for evaluating a StageTip series as presently prepared, and performed a pretreatment of the standard sample by using the StageTip. First, the retention capacity of each of the StageTips was evaluated by varying the accumulating amount of ODS powder on the Empore disk. The recovery ratios of the deoxynucleosides for each quantity of ODS are given in Table 1 . The recovery ratios of the two CPrdG diastereomers gradually increased along with the amount of ODS. The StageTip with an ODS bed of 15 mg accomplished both almost a complete recovery of the DNA adducts and elimination of the normal deoxynucleosides (Table 1) . From these results, we set the ODS quantity to be 15 mg to treat the samples of deoxynucleosides in the following sections.
Total volume injection method
In typical HPLC analyses of real samples, the injection volumes are just fractions of the total volume of the sample solutions previously-treated by solid phase extraction, evaporation or other methods. Therefore, in cases when the availability of samples is limited, an ideal method would be one that allows the total volume of enrichment samples to be loaded onto the analysis systems without losing the sample, in order to achieve utmost sensitivity in the concentration. To meet this need, the present StageTip will be useful because of the small amount of eluent required. Figure 1(b) shows a simple method of total volume injection using the StageTip. A stainless-steel injection needle was connected with the point of the StageTip, and the total eluate of pretreatment samples could be injected into the manual injector.
LC/MS/MS chromatograms of before and after StageTip treatments of four normal deoxynucleosides (UV detection) and CPrdG (MS/MS detection, multiple reaction monitoring (MRM)) are illustrated in Fig. 2 . In this experiment, a large difference in concentration was maintained between the normal deoxynucleosides (10 -4 M) and CPrdG (10 -7 M) in order to evaluate whether the StageTip could also be applied to a real sample. Almost complete recoveries of two CPrdG diastereomers (94.9 ± 3.03% and 110.1 ± 2.29% (n = 3), respectively) and selective enrichment of the DNA adducts were achieved after the StageTip treatment, while the normal nucleosides were removed to a sufficient degree. In fact, the peak height observed for CPrdG-1 by the total volume injection method was 23-times larger compared with that without the StageTip treatment.
Treatment of the adducts as the base forms by the StageTip
In many cases, DNA adducts have been studied as the deoxynucleoside forms obtained by an enzymatic treatment of DNA. However, this requires complex enzymatic reactions and complicated treatment after the reaction. On the other hand, by treating of DNA with hydrochloric acid, purine bases are selectivity cut off from the DNA. Conveniently, MS detection of DNA adducts is more sensitive in base forms than in deoxynucleoside forms. 10 Next, we used CPr-Gua as model DNA adduct bases. Because base forms have higher polarity compared with deoxynucleosides, the recovery ratios were examined with varying ODS amounts. Table 2 gives the recovery ratios under each ODS amount (Ade, CPr-Gua = 10 -4 M each, Gua = saturated). By increasing the ODS amount up to 20 mg, the near-complete recovery of CPr-Gua (92.2 ± 1.56%) and the elimination of adenine and guanine were accomplished simultaneously. From these results, we concluded that the StageTip also applies to sample pretreatments of the bases. The total volume injection was also examined for the sample including CPr-Gua. By a method similar to nucleoside analysis, a sample possessing differential concentrations between the target and normal bases was also prepared. Figure 3 shows UV and MRM chromatograms of adenine (10 -4 M), guanine (saturated), and CPr-Gua (10 -8 M) . Almost all normal bases were eliminated and CPr-Gua was selectively enriched by the StageTip with complete recovery (104.1 ± 14.53% (n = 3)). Furthermore, we accomplished the detection of CPr-Gua at a peak height that was 29-times more sensitive compared with the untreated case by the total volume injection method. The reason for the higher recovery ratio of CPr-Gua in the total volume injection method than that obtained by varying the ODS amount may be attributed to the highly differential concentration of CPr-Gua between the two measurements. Further detailed studies are in progress.
Conclusions
We have developed a convenient pretreatment method that can remove normal deoxynucleosides or normal bases as major ingredients and selectively enrich the DNA adducts as minor ingredients. This StageTip is used as a one-step treatment for DNA adduct analysis that can reduce the possibility of contamination during the pretreatment processes. In addition, by eliminating a large excess of normal deoxynucleosides or bases, damage to the columns is reduced, and the column life can be extended. Moreover, a StageTip can be produced both easily and inexpensively, and used as a disposable device. The total volume injection method allows all enrichment samples to LC/MS systems to increase in concentration sensitivity by more than one order of magnitude. Recently, Kanaly et al. reported the concept of adductome approach using DNA adduct maps, which were designed to detect the neutral loss of 2′-deoxyribose from positively ionized 2′-deoxynucleoside adducts. 1, 11 Most of DNA adducts are more hydrophobic than normal nucleosides or bases, and thus the present StageTip could also be applied to other DNA adducts. Similar to the adductome approach, the DNA-adducts-based approach to elucidate the mutagenesis and carcinogenesis will be increasingly important in the near future. The present StageTip pretreatment method will be useful for DNA adduct analysis.
